+192.7%
QCOM vs CLSK
-84.5%
+277.2%
-44.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | CLSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -7.5% | -16.3% | +8.8% | -7.0% |
| 7D | -13.1% | -26.5% | +13.4% | -12.4% |
| 30D | -15.7% | -44.1% | +28.4% | -14.6% |
| 3M | -6.2% | -61.2% | +55.0% | -4.2% |
| 6M | -25.3% | -68.2% | +43.0% | -23.4% |
| YTD | -11.0% | -51.7% | +40.7% | -9.8% |
| 1Y | -4.1% | -50.0% | +45.9% | -3.0% |
| 3Y | +23.4% | +6.5% | +16.8% | +21.6% |
| 5Y | -9.6% | -72.8% | +63.2% | -11.0% |
| All | +192.7% | -84.5% | +277.2% | +186.0% |
Cumulative growth
Daily Returns
Daily percentage return beside CLSK.
Daily Out/Under-Performance
Portfolio return minus CLSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CLSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded CLSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling